Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy

Publication date

2022-03

Authors

Roudijk, Rob W.
Verheul, Lisa M
Bosman, Laurens P.ORCID 0000-0002-7847-4607
Bourfiss, M
Breur, Johannes M.P.J.ISNI 0000000395622111
Slieker, Martijn GISNI 0000000390873712
Blank, Andreas CORCID 0000-0003-2227-8962
Dooijes, DennisISNI 0000000389750790
van der Heijden, Jeroen FISNI 0000000396634202
van den Heuvel, Freek

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

Objectives: The goal of this study was to describe characteristics, cascade screening results, and predictors of adverse outcome in pediatric-onset arrhythmogenic right ventricular cardiomyopathy (ARVC). Background: Although ARVC is increasingly recognized in children, pediatric ARVC cohorts remain underrepresented in the literature. Methods: This study included 12 probands with pediatric-onset ARVC (aged <18 years at diagnosis) and 68 pediatric relatives (aged <18 years at first evaluation) referred for cascade screening. ARVC diagnosis was based on 2010 Task Force Criteria. Clinical presentation, diagnostic testing, and outcomes (sustained ventricular tachycardia [VT]; heart failure) were ascertained. Predictors of adverse outcome were determined by using univariable logistic regression. Results: Pediatric-onset ARVC was diagnosed in 12 probands and 12 (18%) relatives at a median age of 16.6 years (interquartile range: 13.8-17.4 years), whereas 12 (18%) relatives reached ARVC diagnosis as adults (median age, 22.0 years; interquartile range: 20.0-26.7 years). Sudden cardiac death/arrest was the first disease manifestation in 3 (25%) probands and 3 (4%) relatives. In patients without ARVC diagnosis at presentation (n = 61), electrocardiogram and Holter monitoring abnormalities occurred before development of imaging Task Force Criteria (7.3 ± 5.0 years vs 8.4 ± 5.0 years). Clinical course was characterized by sustained VT (91%) and heart failure (36%) in probands, which were rare in relatives (2% and 0%, respectively). Male sex (P < 0.01), T-wave inversion V1-V3 (P < 0.01), premature ventricular complexes/runs (P ≤ 0.01), and decrease in biventricular ejection fraction (P ≤ 0.01) were associated with VT occurrence. Conclusions: Pediatric ARVC carries high arrhythmic risk, especially in probands. Disease progression is particularly observed on electrocardiogram or Holter monitoring. Arrhythmic events are associated with male sex, T-wave inversions, premature ventricular complexes/runs, and reduced biventricular ejection fraction.

Keywords

arrhythmogenic right ventricular cardiomyopathy, cascade screening, genetics, heart failure, pediatric-onset, sudden cardiac death, ventricular tachycardia, Taverne, Cardiology and Cardiovascular Medicine, Physiology (medical), Journal Article

Citation

Roudijk, R W, Verheul, L, Bosman, L P, Bourfiss, M, Breur, J M P J, Slieker, M G, Blank, A C, Dooijes, D, van der Heijden, J F, van den Heuvel, F, Clur, S A, Udink ten Cate, F E A, van den Berg, M P, Wilde, A A M, Asselbergs, F W, Peter van Tintelen, J & te Riele, A S J M 2022, 'Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy', JACC. Clinical electrophysiology, vol. 8, no. 3, pp. 306-318. https://doi.org/10.1016/j.jacep.2021.09.001